Literature DB >> 2306178

Patterns of failure in anorectal melanoma. A guide to surgical therapy.

M Ross1, C Pezzi, T Pezzi, D Meurer, R Hickey, C Balch.   

Abstract

Anorectal melanoma is an aggressive tumor with a reported 5-year survival rate of 6%. Recommendations for local surgical therapy vary from local excision to abdominoperineal resection. Therapy, patterns of failure, and survival were retrospectively examined in 32 patients with anorectal melanoma. Twenty-six patients were treated surgically, 14 with abdominoperineal resection and 12 with local excision. Local recurrence occurred less frequently in patients undergoing abdominoperineal resection (4 [29%] of 14) compared with patients undergoing local excision (7 [58%] of 12) but developed concomitantly with distant or regional metastasis in all but 2 of the 11 patients whose operations failed locally. Inguinal nodal disease developed in 15 patients (47%). Pelvic nodal disease became apparent in only 2 patients (7%). There was no difference in overall survival between the two surgically treated groups (median survival, 19.5 months for patients treated with abdominoperineal resection vs 18.9 months for patients treated with local excision). Therefore, local excision is recommended when technically feasible since these patients eventually succumb to metastasis regardless of surgical therapy.

Entities:  

Mesh:

Year:  1990        PMID: 2306178     DOI: 10.1001/archsurg.1990.01410150035007

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  39 in total

1.  Anorectal malignant melanomas: retrospective experience with surgical management.

Authors:  Xu Che; Dong-Bing Zhao; Yong-Kai Wu; Cheng-Feng Wang; Jian-Qiang Cai; Yong-Fu Shao; Ping Zhao
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  A pilot study of extralevator abdominoperineal excision for primary melanoma of the anorectum.

Authors:  H J M Ferguson; S Nandi; R K Hejmadi; T Ismail
Journal:  Tech Coloproctol       Date:  2014-08-26       Impact factor: 3.781

3.  Anorectal Malignant Melanoma-Defining the Optimal Surgical Treatment and Prognostic Factors.

Authors:  Syed Nusrath; Subramanyeshwar Rao Thammineedi; Sujit Chyau Patnaik; K V V N Raju; Satish Pawar; Vipin Goel; Ramachandra Nagaraju Chavali; Sudha Murthy
Journal:  Indian J Surg Oncol       Date:  2018-07-23

Review 4.  Anorectal melanoma. Successful palliation in a 59-year-old woman.

Authors:  S P Mostafapour; J Morris; J P Sherck
Journal:  West J Med       Date:  1996-05

Review 5.  Rare presentations of primary melanoma and special populations: a systematic review.

Authors:  Lisa A Kottschade; Travis E Grotz; Roxana S Dronca; Diva R Salomao; Jose S Pulido; Nabil Wasif; James W Jakub; Sanjay P Bagaria; Riten Kumar; Judith S Kaur; Shane Y Morita; Steven L Moran; Jesse T Nguyen; Emily C Nguyen; Jennifer L Hand; Lori A Erickson; Jerry D Brewer; Christian L Baum; Robert C Miller; David L Swanson; Val Lowe; Svetomir N Markovic
Journal:  Am J Clin Oncol       Date:  2014-12       Impact factor: 2.339

6.  Anal melanoma.

Authors:  Marc Singer; Matthew G Mutch
Journal:  Clin Colon Rectal Surg       Date:  2006-05

7.  Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?

Authors:  Douglas M Iddings; Ani J Fleisig; Steven L Chen; Mark B Faries; Donald L Morton
Journal:  Ann Surg Oncol       Date:  2009-09-23       Impact factor: 5.344

Review 8.  Primary mucosal melanomas: a comprehensive review.

Authors:  Marija Mihajlovic; Slobodan Vlajkovic; Predrag Jovanovic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

9.  Anorectal malignant melanoma: treatment with surgery or radiation therapy, or both.

Authors:  Kouros L Moozar; C Shun Wong; Jean Couture
Journal:  Can J Surg       Date:  2003-10       Impact factor: 2.089

10.  What is the best surgical treatment for anorectal melanoma?

Authors:  Amara Malik; Tracy L Hull; Crina Floruta
Journal:  Int J Colorectal Dis       Date:  2003-08-27       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.